Skip to main content

Table 3 Prevalence of potent anticholinergic use in CFAS I and CFAS II, by drug class

From: Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II

Potent anticholinergic class 1991 CFAS I 2011 CFAS II
Urological 0.3 (0.2, 0.4) 2.8 (2.4, 3.2)
Antispasmodic 0.5 (0.3, 0.6) 0.3 (0.2, 0.5)
Antipsychotic 1.0 (0.8, 1.2) 0.9 (0.7, 1.1)
Antidepressant 4.0 (3.6, 4.5) 5.9 (5.4, 6.5)
Anxiolytic N/A 0.2 (0.1, 0.3)
Parkinsonian 0.2 (0.2, 0.4) 0.1 (0.0, 0.2)
Antihistamine 0.2 (0.1, 0.3) 0.5 (0.3, 0.7)
  1. Cell entries denote % prevalence (95% confidence intervals)
  2. Abbreviations: CFAS Cognitive Function and Ageing Studies